Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping

Keyphrases

• Genetic Modification 100%
• Metastasis 100%
• Hormone-sensitive Prostate Cancer 100%
• Allelotyping 100%
• Comparative Genomic Hybridization 100%
• Tumor 66%
• Comparative Genomic Hybridization Analysis 66%
• Color Ratio 66%
• Chromosomal Alterations 66%
• Chromosomal Region 33%
• Evenly Distributed 33%
• Prostate Cancer 33%
• Oncogene 33%
• Prostate Cancer Progression 33%
• Statistical Comparison 33%
• Copy number 33%
• Recurrent Tumor 33%
• Tumor-specific 33%
• Prostate Radiotherapy 33%
• Tumor DNA 33%
• Metastatic Disease 33%
• Primary Tumor 33%
• Advanced Prostate Cancer 33%
• Prostate Cancer Metastasis 33%
• Androgen Deprivation Therapy 33%
• Human Genome 33%
• Cancer Tissue 33%
• Metastatic Tumor 33%
• Tumor Genome 33%
• Microsatellites 33%
• Progression Rate 33%
• Androgen-independent 33%
• Informative Loci 33%
• Chromosome 11p 33%
• Tumor-normal 33%
• Chromosome Arms 33%
• African American Patients 33%
• 4q25 33%
• Androgen Deprivation 33%
• 8q Gain 33%

Biochemistry, Genetics and Molecular Biology

• Gene Mutation 100%
• Comparative Genomic Hybridization 100%
• Oncogene 20%
• Human Genome 20%
• Chromosome 2q 20%
• Chromosome Arm 20%
• Chromosome 11p 20%
• Microsatellite 20%
• Chromosome 20%